Polly Niravath

2.2k total citations
53 papers, 970 citations indexed

About

Polly Niravath is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Polly Niravath has authored 53 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 16 papers in Cancer Research. Recurrent topics in Polly Niravath's work include Advanced Breast Cancer Therapies (17 papers), HER2/EGFR in Cancer Research (14 papers) and Cancer Treatment and Pharmacology (14 papers). Polly Niravath is often cited by papers focused on Advanced Breast Cancer Therapies (17 papers), HER2/EGFR in Cancer Research (14 papers) and Cancer Treatment and Pharmacology (14 papers). Polly Niravath collaborates with scholars based in United States, Canada and Japan. Polly Niravath's co-authors include Swapan Dasgupta, Rolando E. Rumbaut, Shigekazu Nagata, Anhquyen Le, Hanan Abdel‐Monem, Perumal Thiagarajan, Mothaffar F. Rimawi, Susan G. Hilsenbeck, Meghana V. Trivedi and Tao Wang and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Polly Niravath

49 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Polly Niravath United States 14 456 227 209 195 151 53 970
Anne Moore United States 14 770 1.7× 399 1.8× 145 0.7× 198 1.0× 58 0.4× 30 1.2k
Susan A. Melin United States 17 375 0.8× 84 0.4× 258 1.2× 105 0.5× 42 0.3× 35 1.1k
Mitsue Saito Japan 20 738 1.6× 358 1.6× 342 1.6× 336 1.7× 75 0.5× 119 1.7k
Gustavo de la Roza United States 15 283 0.6× 106 0.5× 705 3.4× 261 1.3× 58 0.4× 39 1.1k
Masaharu Nishikido Japan 18 266 0.6× 137 0.6× 403 1.9× 337 1.7× 91 0.6× 58 1.0k
Atif Hussein United States 18 311 0.7× 62 0.3× 221 1.1× 132 0.7× 25 0.2× 59 829
Tao Jin China 18 288 0.6× 83 0.4× 289 1.4× 203 1.0× 41 0.3× 73 1.0k
Sung Hoon Sim South Korea 18 493 1.1× 230 1.0× 325 1.6× 243 1.2× 31 0.2× 81 1.0k
Mükremın Uysal Türkiye 14 300 0.7× 87 0.4× 198 0.9× 151 0.8× 97 0.6× 74 683
Joost R.M. van der Sijp Netherlands 27 453 1.0× 214 0.9× 244 1.2× 194 1.0× 111 0.7× 39 1.5k

Countries citing papers authored by Polly Niravath

Since Specialization
Citations

This map shows the geographic impact of Polly Niravath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Polly Niravath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Polly Niravath more than expected).

Fields of papers citing papers by Polly Niravath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Polly Niravath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Polly Niravath. The network helps show where Polly Niravath may publish in the future.

Co-authorship network of co-authors of Polly Niravath

This figure shows the co-authorship network connecting the top 25 collaborators of Polly Niravath. A scholar is included among the top collaborators of Polly Niravath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Polly Niravath. Polly Niravath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chau, Eric, Anjana Tiwari, Yitian Xu, et al.. (2024). Characterization of the Breast Cancer Liver Metastasis Microenvironment via Machine Learning Analysis of the Primary Tumor Microenvironment. Cancer Research Communications. 4(10). 2846–2857. 2 indexed citations
3.
Patel, Tejal, et al.. (2022). Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastases. Breast Cancer Research and Treatment. 193(3). 613–623. 3 indexed citations
4.
Niravath, Polly, et al.. (2021). Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration: Case Series and Review of Literature. Cureus. 13(12). e20203–e20203. 6 indexed citations
5.
Lewis, Gary D., Waqar Haque, Andrew Farach, et al.. (2021). The impact of HER2-directed targeted therapy on HER2-positive DCIS of the breast. Reports of Practical Oncology & Radiotherapy. 26(2). 179–187. 4 indexed citations
6.
Niravath, Polly, et al.. (2020). Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data. ERJ Open Research. 6(2). 199–2020. 6 indexed citations
7.
Rimawi, Mothaffar F., Polly Niravath, Tao Wang, et al.. (2019). TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer. Clinical Cancer Research. 26(4). 821–827. 34 indexed citations
8.
Haque, Waqar, Vivek Verma, Mary R. Schwartz, et al.. (2019). Comparison of outcomes between metaplastic and triple-negative breast cancer patients. The Breast. 49. 8–16. 29 indexed citations
9.
Gauthier, Geneviève, Patrick Gagnon‐Sanschagrin, Annie Guérin, et al.. (2018). Economic Burden of HR+/HER2- Metastatic Breast Cancer Among Adult Premenopausal Women. Advances in Therapy. 35(4). 503–514. 9 indexed citations
10.
Guérin, Annie, Patrick Gagnon‐Sanschagrin, Geneviève Gauthier, et al.. (2018). Monitoring of Hematologic, Cardiac, and Hepatic Function in Post-Menopausal Women with HR+/HER2− Metastatic Breast Cancer. Advances in Therapy. 35(8). 1251–1264. 1 indexed citations
11.
Goldschmidt, Deborah, Anand A. Dalal, Sneha S. Kelkar, et al.. (2018). Current Treatment Patterns Among Postmenopausal Women with HR+/HER2− Metastatic Breast Cancer in US Community Oncology Practices: An Observational Study. Advances in Therapy. 35(4). 482–493. 9 indexed citations
12.
Ayyagari, Rajeev, Derek Tang, Oscar Patterson‐Lomba, et al.. (2018). Progression-free Survival With First-line Endocrine-based Therapies Among Postmenopausal Women With HR+/HER2– Metastatic Breast Cancer:. Clinical Therapeutics. 40(4). 628–639.e3. 9 indexed citations
13.
Vadhariya, Aisha, et al.. (2018). Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?. Journal of Cancer Survivorship. 12(3). 348–356. 50 indexed citations
14.
Niravath, Polly, Bingshu E. Chen, Judy-Anne W. Chapman, et al.. (2017). Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27. Clinical Breast Cancer. 18(1). 78–87. 19 indexed citations
15.
Niravath, Polly, Melissa L. Bondy, & Susan G. Hilsenbeck. (2016). Unique Breast Cancer Features Within the Vietnamese Population. Digital Scholarship - UNLV (University of Nevada Reno). 9(4). 5.
16.
Haque, Waqar, Awad A. Ahmed, Mary R. Schwartz, et al.. (2016). Prognostic Factors, Treatment, and Outcomes in Early Stage, Invasive Papillary Breast Cancer. American Journal of Clinical Oncology. 41(6). 532–537. 7 indexed citations
17.
Wang, Weiqun, et al.. (2016). Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy. Breast Cancer Research and Treatment. 157(2). 203–210. 21 indexed citations
18.
19.
Niravath, Polly, Tanya N. Eble, Alejandro Contreras, et al.. (2015). Breast adenocarcinoma recurring as small cell carcinoma in a patient with a germline BRCA2 mutation: clonal evolution unchecked. Experimental Hematology and Oncology. 4(1). 1–1. 3 indexed citations
20.
Niravath, Polly, Teresa G. Hayes, & Susan G. Hilsenbeck. (2011). Utility of screening for hepatocellular carcinoma among cirrhotics. Frontline Gastroenterology. 2(3). 182–187. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Moore Breakdown of academic impact, for papers by Susan A. Melin Breakdown of academic impact, for papers by Mitsue Saito Breakdown of academic impact, for papers by Gustavo de la Roza Breakdown of academic impact, for papers by Masaharu Nishikido Breakdown of academic impact, for papers by Atif Hussein Breakdown of academic impact, for papers by Tao Jin Breakdown of academic impact, for papers by Sung Hoon Sim Breakdown of academic impact, for papers by Mükremın Uysal Breakdown of academic impact, for papers by Joost R.M. van der Sijp
Rankless by CCL
2026